Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource limited setting in rural Lesotho.

Jouquet, G; Bygrave, H; Kranzer, K; Ford, N; Gadot, L; Lee, J; Hilderbrand, K; Goemaere, E; Vlahakis, N; Trivino, L; +2 more... Makakole, L; Cleary, S; (2011) Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource limited setting in rural Lesotho. Journal of acquired immune deficiency syndromes (1999), 58 (3). e68-74. ISSN 1525-4135 DOI: https://doi.org/10.1097/QAI.0b013e31822a9f8d

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1097/QAI.0b013e31822a9f8d

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar